Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

Clinical trial NCT02484443 · COMPLETED

Trial details

NCT number: NCT02484443
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Lung Metastatic Osteosarcoma Recurrent Osteosarcoma

Start date: 2016-02-04
Primary completion: 2020-03-31
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.